Activating the ERBB family leads to the stimulation of key pathways such as the MAPK pathway, STAT3 signalling, and the PI3K–Akt pathway, which are primarily associated with cell proliferation and tumour cell survival [22,23,24]. Here, EGFR is linked to neoplasm.